Siga Technologies INC Number of Reportable Segments
Siga Technologies INC (SIGA) reported Number of Reportable Segments of 100.00% for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfReportableSegments · last filed 2026-08-06
- Siga Technologies INC number of reportable segments for the quarter ending 2026-03-31 was 100.00%, a 0.00% change year-over-year.
- Siga Technologies INC number of reportable segments for the quarter ending 2025-03-31 was 100.00%.
- Siga Technologies INC number of reportable segments for fiscal 2025 was 100.00%, a 0.00% change from fiscal 2024.
- Siga Technologies INC number of reportable segments for fiscal 2024 was 100.00%, a 0.00% change from fiscal 2023.
- Siga Technologies INC number of reportable segments for fiscal 2023 was 100.00%, a 0.00% change from fiscal 2022.
- Siga Technologies INC number of reportable segments for fiscal 2022 was 100.00%, a 0.00% change from fiscal 2021.
| Period end | Number of Reportable Segments 3 month | Number of Reportable Segments 6 month | Number of Reportable Segments 9 month | Number of Reportable Segments 12 month |
|---|---|---|---|---|
| 2026-06-30 | 100.00% 10-Q · filed 2026-08-06 | |||
| 2026-03-31 | 100.00% 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | 100.00% 10-K · filed 2026-03-10 | |||
| 2025-09-30 | 100.00% 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | 100.00% 10-Q · filed 2025-08-05 | |||
| 2025-03-31 | 100.00% 10-Q · filed 2025-05-08 | |||
| 2024-12-31 | 100.00% 10-K · filed 2025-03-11 | |||
| 2023-12-31 | 100.00% 10-K · filed 2024-03-12 | |||
| 2022-12-31 | 100.00% 10-K · filed 2023-03-02 | |||
| 2021-12-31 | 100.00% 10-K · filed 2022-03-03 | |||
| 2020-12-31 | 100.00% 10-K · filed 2021-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |